198 related articles for article (PubMed ID: 21439677)
1. [Genomic techniques used in uveal melanoma: a literature review].
Abi-Ayad N; Kodjikian L; Couturier J
J Fr Ophtalmol; 2011 Apr; 34(4):259-64. PubMed ID: 21439677
[TBL] [Abstract][Full Text] [Related]
2. Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases.
Trolet J; Hupé P; Huon I; Lebigot I; Decraene C; Delattre O; Sastre-Garau X; Saule S; Thiéry JP; Plancher C; Asselain B; Desjardins L; Mariani P; Piperno-Neumann S; Barillot E; Couturier J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2572-80. PubMed ID: 19151381
[TBL] [Abstract][Full Text] [Related]
3. Multiplex ligation-dependent probe amplification equals fluorescence in-situ hybridization for the identification of patients at risk for metastatic disease in uveal melanoma.
Vaarwater J; van den Bosch T; Mensink HW; van Kempen C; Verdijk RM; Naus NC; Paridaens D; Brüggenwirth HT; Kiliç E; de Klein A
Melanoma Res; 2012 Feb; 22(1):30-7. PubMed ID: 22157614
[TBL] [Abstract][Full Text] [Related]
4. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma.
Lake SL; Coupland SE; Taktak AF; Damato BE
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4884-91. PubMed ID: 20445121
[TBL] [Abstract][Full Text] [Related]
5. Molecular karyotyping for detection of prognostic markers in fine needle aspiration biopsy samples of uveal melanoma.
Ganguly A; Richards-Yutz J; Ewens KG
Methods Mol Biol; 2014; 1102():441-58. PubMed ID: 24258992
[TBL] [Abstract][Full Text] [Related]
6. Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication.
Minca EC; Tubbs RR; Portier BP; Wang Z; Lanigan C; Aronow ME; Triozzi PL; Singh A; Cook JR; Saunthararajah Y; Plesec TP; Schoenfield L; Cawich V; Sulpizio S; Schultz RA
Cancer Genet; 2014; 207(7-8):306-15. PubMed ID: 25442074
[TBL] [Abstract][Full Text] [Related]
7. Molecular cytogenetic evaluation of 10 uveal melanoma cell lines.
White JS; Becker RL; McLean IW; Director-Myska AE; Nath J
Cancer Genet Cytogenet; 2006 Jul; 168(1):11-21. PubMed ID: 16772116
[TBL] [Abstract][Full Text] [Related]
8. Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases.
Petrausch U; Martus P; Tönnies H; Bechrakis NE; Lenze D; Wansel S; Hummel M; Bornfeld N; Thiel E; Foerster MH; Keilholz U
Eye (Lond); 2008 Aug; 22(8):997-1007. PubMed ID: 17384575
[TBL] [Abstract][Full Text] [Related]
9. High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy.
Young TA; Burgess BL; Rao NP; Gorin MB; Straatsma BR
Mol Vis; 2007 Dec; 13():2328-33. PubMed ID: 18199974
[TBL] [Abstract][Full Text] [Related]
10. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetics and prognosis for uveal melanoma in Korean patients.
Lee CS; Lee J; Choi JJ; Yang WI; Yoon JS; Lee SY; Lee SC
Acta Ophthalmol; 2011 Jun; 89(4):e310-4. PubMed ID: 21310015
[TBL] [Abstract][Full Text] [Related]
12. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
Parrella P; Caballero OL; Sidransky D; Merbs SL
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
[TBL] [Abstract][Full Text] [Related]
13. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of chromogenic in situ hybridization for the determination of monosomy 3 in uveal melanoma.
Gleeson G; Larkin A; Horgan N; Kennedy S
Arch Pathol Lab Med; 2014 May; 138(5):664-70. PubMed ID: 24786124
[TBL] [Abstract][Full Text] [Related]
15. Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma.
Cross NA; Ganesh A; Parpia M; Murray AK; Rennie IG; Sisley K
Eye (Lond); 2006 Apr; 20(4):476-81. PubMed ID: 15920570
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
[TBL] [Abstract][Full Text] [Related]
17. Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization.
Naus NC; van Drunen E; de Klein A; Luyten GP; Paridaens DA; Alers JC; Ksander BR; Beverloo HB; Slater RM
Genes Chromosomes Cancer; 2001 Mar; 30(3):267-73. PubMed ID: 11170284
[TBL] [Abstract][Full Text] [Related]
18. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization.
Naus NC; Verhoeven AC; van Drunen E; Slater R; Mooy CM; Paridaens DA; Luyten GP; de Klein A
Clin Cancer Res; 2002 Feb; 8(2):534-9. PubMed ID: 11839674
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3.
Nareyeck G; Zeschnigk M; Prescher G; Lohmann DR; Anastassiou G
Exp Eye Res; 2006 Oct; 83(4):858-64. PubMed ID: 16750193
[TBL] [Abstract][Full Text] [Related]
20. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome.
Mensink HW; Kiliç E; Vaarwater J; Douben H; Paridaens D; de Klein A
Cancer Genet Cytogenet; 2008 Mar; 181(2):108-11. PubMed ID: 18295662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
